RHOA and lung cancer: Additionally, as a downstream effector of RhoA GTPase, ANLN activates RhoA-mediated signaling to enhance actomyosin contractility, a mechanism recognized as essential for promoting lung cancer cell migration and invasion (Suzuki et al., 2005).